3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Immunoblastic Lymphadenopathy
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
duvelisib
×
1 year
×
Clear all
No trials found.